TrialSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2016

Phase II study to evaluate the safety and efficacy of intravenous palonosetron (PAL) in primary malignant glioma (MG) patients receiving standard radiotherapy (RT) and concomitant temozolomide (TMZ).

Mary Lou Affronti et al.PubMed ↗Publisher ↗

No numbers read from the abstract.